BSE filing, NSE: GOKEX. Summary written from the filing by ALFA Finder's alert engine.
Gokaldas Exports Ltd: key numbers
- Share price
- ₹648.55
- Market cap
- ₹4,752 Cr
- Revenue (annual)
- ₹3,988 Cr
- Net profit (annual)
- ₹100.1 Cr
- P/E (TTM)
- 46.2×Sector 49.0×
- Promoter holding
- 9.15%+0.00% QoQ
- FII holding
- 13.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gokaldas Exports Ltd
All →Gokaldas Exports Other Announcement
Quarterly shareholding pattern disclosure for the period ended September 30, 2026, as required under SEBI regulations.
Gokaldas Exports Annual General Meeting
Gokaldas Exports held its 23rd Annual General Meeting. Shareholders adopted the financial statements and re-appointed Mr. Mathew Cyriac as Chairman and Non-Executive Director.
Gokaldas Exports Annual General Meeting
Gokaldas Exports Limited has scheduled its 23rd Annual General Meeting for September 28, 2026, via video conferencing. The meeting will address ordinary business for shareholders.
Gokaldas Exports Annual Report
Gokaldas Exports Ltd has submitted its Annual Report for the financial year 2025-26, in compliance with Regulation 34 of the SEBI LODR Regulations, 2015.
Gokaldas Exports Earnings Call Transcript: Key Takeaways
Gokaldas reported strong revenue growth of 21% YoY, outperforming a declining Indian garment export market. Growth was fueled by strategic African expansion and capacity ramp-ups despite intense wage and logistical cost pressures.
- Call
- Guides 18% growth
Gokaldas Exports Investor Presentation: Key Takeaways
Gokaldas Exports delivered strong Q1FY27 results with consolidated income rising 21% YoY to ₹1,180 Cr, driven by robust performance in India and Africa business despite industry headwinds.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.